38 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• Biocept, Inc. BIOC shares rose 73.6 percent to $1.19 after the company entered a software license and laboratory data supply agreement with Prognos.
• Marin Software Incorporated MRIN shares climbed 37.8 percent to $3.94 after the company announced it has entered a revenue sharing agreement with Google. The company also raised Q4 guidance.
• Navistar International Corporation NAV rose 17.8 percent to $28.08 after the company reported better-than-expected results for its fourth quarter.
• ReShape Lifesciences Inc. RSLS gained 15.5 percent to $0.4750 after the company acquired Apollo Endosurgery's lap-band system.
• Kodiak Sciences Inc. KOD shares climbed 15.3 percent to $7.68.
• CollPlant Holdings Ltd. CLGN shares gained 14.2 percent to $4.98.
• Materialise NV MTLS shares climbed 12.9 percent to $17.82.
• Limbach Holdings, Inc. LMB gained 12.1 percent to $3.99.
• The Meet Group, Inc. MEET rose 11.3 percent to $3.7511. The Meet Group reported that annualized video revenue run-rate rose to $62 million in November, up from $55 million in October.
• Tyme Technologies, Inc. TYME gained 10.5 percent to $3.58.
• NRC Group Holdings Corp. NRCG climbed 9.4 percent to $9.31.
• SMART Global Holdings, Inc. SGH rose 9.2 percent to $30.65. SMART Global will replace XO Group in the S&P SmallCap 600 on Monday, December 24.
• Tilray, Inc. TLRY climbed 8.1 percent to $71.20 after the company announced a partnership with German pharmaceutical company Sandoz to distribute non-smokable medical cannabis products.
• Boot Barn Holdings, Inc. BOOT climbed 7.6 percent to $17.12.
• Scientific Games Corporation SGMS shares rose 7.5 percent to $17.05.
• Cellect Biotechnology Ltd. APOP shares gained 6.8 percent to $2.67.
• HealthEquity, Inc. HQY gained 6.6 percent to $63.59. Cantor Fitzgerald upgraded Healthequity from Neutral to Overweight.
• HEICO Corporation HEI climbed 5.9 percent to $82.44 after the company beat Q4 EPS and sales estimates.
• FibroGen, Inc. FGEN rose 5.6 percent to $41.17 after the company said its China unit has received marketing authorization from the National Medical Products Administration for Roxadustat, a hypoxia-inducible factor propyl hydroxylase inhibitor for treating patients with anemia caused by chronic kidney disease, who are dialysis dependent.
• NCR Corporation NCR shares gained 5.3 percent to $23.90. RBC Capital upgraded NCR from Outperform to Top Pick.
• Puma Biotechnology, Inc. PBYI rose 5 percent to $22.48 after the company reported favorable results from its Phase III NALA trial of Neratinib in breast cancer patients.

Check out these big penny stock gainers and losers

Losers

• Nemaura Medical Inc. NMRD shares tumbled 39.2 percent to $0.8450 after the company priced its $2.5 million share common stock offering at $1.02 per share.
• Champions Oncology, Inc. CSBR shares declined 18.4 percent to $7.79. Champions Oncology reported Q2 revenues of $6.7 million, up 28.6 percent year-over-year, and non-GAAP EPS of 3 cents compared to break-even results a year ago.
• Diffusion Pharmaceuticals Inc. DFFN dipped 17.4 percent to $2.33.
• OptimizeRx Corporation OPRX dipped 16.8 percent to $9.65 after the company priced its offering of approximately 2.1 million shares at $10 per share.
• Dova Pharmaceuticals, Inc. DOVA shares fell 16.3 percent to $7.54.
• Cancer Genetics, Inc. CGIX dipped 15.9 percent to $0.2800 on continued weakness after the company on Monday announced it has terminated its proposed merger with NovellusDx.
• Motus GI Holdings, Inc. MOTS shares dropped 15.8 percent to $2.6942 after reporting a proposed 5 million share follow-on offering of common stock.
• Rent-A-Center, Inc. RCII fell 15.6 percent to $12.19 after terminating its merger agreement with Vintage Capital.
• Achillion Pharmaceuticals, Inc. ACHN shares dropped 14.8 percent to $2.0450 after the company reported positive interim Phase 2 trials of its first-gen oral factor D inhibitor ACH-4471, as well as pharmacokinetics and potency data for its next-gen factor D inhibitors ACH-5228 and ACH-5548.
• Evofem Biosciences, Inc. EVFM fell 14.3 percent to $3.4700 after climbing 15.71 percent on Monday.
• NF Energy Saving Corporation NFEC dropped 12.4 percent to $9.35.
• Worthington Industries, Inc. WOR shares fell 10.9 percent to $32.67 after the company posted downbeat Q2 results.
• Integrated Media Technology Limited IMTE dropped 9.1 percent to $4.41.
• Eyenovia, Inc. EYEN shares tumbled 8.7 percent to $2.83.
• RiceBran Technologies RIBT dipped 7.4 percent to $3.11.
• Washington Prime Group Inc. WPG fell 7.2 percent to $5.36 after dropping 6.18 percent on Monday. Goldman Sachs downgraded Washington Prime Group from Neutral to Sell.
• Comstock Resources, Inc. CRK dropped 6.6 percent to $4.68.